0001209191-19-004549.txt : 20190118
0001209191-19-004549.hdr.sgml : 20190118
20190118161331
ACCESSION NUMBER: 0001209191-19-004549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190116
FILED AS OF DATE: 20190118
DATE AS OF CHANGE: 20190118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirson Eilon D.
CENTRAL INDEX KEY: 0001654356
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19533389
MAIL ADDRESS:
STREET 1: TOPAZ BUILDING, MATAN CENTER
CITY: HAIFA
STATE: L3
ZIP: 31905
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-16
0
0001645113
NovoCure Ltd
NVCR
0001654356
Kirson Eilon D.
C/O NOVOCURE INC.,
VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Science Officer
Ordinary Shares
2019-01-16
4
M
0
100000
14.37
A
209063
D
Ordinary Shares
2019-01-16
4
S
0
100000
45.11
D
109063
D
Ordinary Shares
2019-01-17
4
M
0
68813
14.37
A
177876
D
Ordinary Shares
2019-01-17
4
S
0
68813
45.25
D
109063
D
Options to Buy Ordinary Shares
14.37
2019-01-16
4
M
0
100000
0.00
D
2025-02-23
Ordinary Shares
100000
135335
D
Options to Buy Ordinary Shares
14.37
2019-01-17
4
M
0
68813
0.00
D
2025-02-23
Ordinary Shares
68813
66522
D
Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.
On January 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 100,000 shares in multiple trades at prices ranging from $45.00 to $45.36. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 17, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 68,813 shares in multiple trades at prices ranging from $45.00 to $45.66. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested and currently exercisable as of the date hereof.
By: /s/ Kimberly Burke, Attorney in fact for Eilon D. Kirson
2019-01-18